Floatz logo

Therapeutic Asset Ratings

245 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Netupitant
Breast Cancer Patients Treated With T-DXd
Tianjin Medical University Cancer Institute and HospitalP4BBB (75)
Irinotecan
Recurrent Ovarian Carcinoma
Tianjin Medical University Cancer Institute and HospitalP4BBB (74)
Palonosetron
Breast Cancer Patients Treated With T-DXd
Tianjin Medical University Cancer Institute and HospitalP4BBB (74)
DEXAMETHASONE
Anatomic Stage IA Breast Cancer AJCC v8
Tianjin Medical University Cancer Institute and HospitalP4BBB (73)
Eloxatin
Gallbladder Cancer
Tianjin Medical University Cancer Institute and HospitalP3BBB (72)
Inno-206
Recurrent Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and HospitalP3BBB (72)
DEXAMETHASONE
Metastatic Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalP4BB (70)
FENTANYL
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and HospitalP4BB (70)
MEGESTROL ACETATE IMPURITY B
Breast Cancer Patients Treated With T-DXd
Tianjin Medical University Cancer Institute and HospitalP4BB (70)
Eloxatin
Gall Bladder Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (70)
Osimertinib
EGFR Activating Mutation
Tianjin Medical University Cancer Institute and HospitalP3BB (70)
TRASTUZUMAB
Hormone Receptor Positive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (70)
Irinotecan
Primary Peritoneal Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (69)
Capecitabine
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (68)
Irinotecan
Fallopian Tube Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (68)
Osimertinib
EGFR-TKI Resistant Mutation
Tianjin Medical University Cancer Institute and HospitalP3BB (68)
DEXKETOPROFEN
Carcinoma, Hepatocellular
Tianjin Medical University Cancer Institute and HospitalP4BB (67)
METAMIZOLE
Carcinoma, Hepatocellular
Tianjin Medical University Cancer Institute and HospitalP4BB (67)
CIS-DIAMMINEDICHLOROPLATINUM II
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (67)
Bxcl501
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (66)
NEPENTHE
Carcinoma, Hepatocellular
Tianjin Medical University Cancer Institute and HospitalP4BB (66)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
Capecitabine
Metastatic Colorectal Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
Capecitabine
Pancreatic Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
HR+ Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
Showing 1 to 25 of 245 assets
PreviousPage 1 of 10Next